Xenon Pharmaceuticals (XENE) Debt Ratio (2017 - 2020)

Xenon Pharmaceuticals (XENE) has 4 years of Debt Ratio data on file, last reported at 0.07 in Q1 2020.

• On a quarterly basis, Debt Ratio fell 49.96% year-over-year to 0.07 in Q1 2020; TTM through Mar 2020 was 0.07, a 49.96% decrease from a year earlier, with the FY2019 full-year figure at 0.11, down 14.21% from the prior year.
• Debt Ratio for Q1 2020 stood at 0.07, down from 0.11 in the prior quarter.
• Over the last five years, Debt Ratio for XENE reached as high as 0.18 in Q1 2018 and fell as low as 0.07 in Q1 2020.
• Historically, Debt Ratio has averaged 0.13 across 4 years, with a median of 0.14 in 2019.
• Across the five-year window, Debt Ratio surged 36.47% in 2019 and plunged 49.96% in 2020, its largest moves.
• Year by year, Debt Ratio stood at 0.15 in 2017, then declined by 16.87% to 0.12 in 2018, then decreased by 14.21% to 0.11 in 2019, then slumped by 37.14% to 0.07 in 2020.
• Per Business Quant data, the three most recent Debt Ratio figures were 0.07 in Q1 2020, 0.11 in Q4 2019, and 0.16 in Q3 2019.